The Chicago Clinical Trials Unit (CCTU) is a highly productive and adaptable consortium with three successful Clinical Research Sites: Northwestern and Rush Clinical Research Sites in Chicago and the Trinity Clinical Research Site in Dallas, Texas. These CRSs have been at the forefront of their local/regional responses to Coronavirus Disease 2019 (COVID-19). The CTU is requesting supplemental funding to advance this work. The overarching goal is to amplify the response to the COVID-19 public health emergency through expanded testing at the three CRSs.
|Effective start/end date||6/17/20 → 11/30/20|
- National Institute of Allergy and Infectious Diseases (3UM1AI069471-14S1)